Free shipping on all orders over $ 500

PF-07054894

Cat. No. M25595

All AbMole products are for research use only, cannot be used for human consumption.

PF-07054894 Structure
Size Price Availability Quantity
1mg USD 600  USD600 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Chemical Information
Molecular Weight 466.53
Formula C24H30N6O4
CAS Number 2413693-96-4
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Wei Li, et al. J Pharmacol Exp Ther. A Novel C-C Chemoattractant Cytokine (Chemokine) Receptor 6 (CCR6) Antagonist (PF-07054894) Distinguishes between Homologous Chemokine Receptors, Increases Basal Circulating CCR6+ T Cells, and Ameliorates Interleukin-23-Induced Skin Inflammatio

Related CCR Products
C-021 dihydrochloride

C-021 dihydrochloride is a potent CC chemokine receptor-4 (CCR4) antagonist. C-021 dihydrochloride potently inhibits functional chemotaxis in human and mouse with IC50s of 140 nM and 39 nM, respectively.

C-021

C-021 is a potent CC chemokine receptor-4 (CCR4) antagonist. C-021 potently inhibits functional chemotaxis in human and mouse with IC50s of 140 nM and 39 nM, respectively.

AZD-5672 

AZD-5672 is an orally active, potent, and selective CCR5 antagonist (IC50=0.32 nM).

MLN3126 

MLN3126 is an orally active and potent CCR9 antagonist.

AZD2423 

AZD2423 is a potent, selective, orally bioavailable, and non-competitive CCR2 chemokine receptor negative allosteric modulator.

  Catalog
Abmole Inhibitor Catalog




Keywords: PF-07054894 supplier, CCR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.